Comments on: Bouncing Back From Trial Failure, Travere Wins First FDA Approval in Rare Kidney Disease https://medcitynews.com/2026/04/travere-therapeutics-filspari-sparsentan-fda-approval-rare-kidney-disease-proteinuria-fsgs-tvtx/ Healthcare technology news, life science current events Thu, 16 Apr 2026 15:30:03 +0000 hourly 1 https://wordpress.org/?v=6.8.5